(Press-News.org) BLOOMINGTON, Ind. -- An Indiana University study has found that a unique omega-3 supplement derived from the New Zealand green-lipped mussel significantly improved lung function and reduced airway inflammation in asthmatics who experience exercise-induced bronchoconstriction, also called exercise-induced asthma.
Timothy Mickleborough, professor in the IU School of Public Health-Bloomington, said his findings are similar to his studies involving fish oil but required a much smaller dosage of the supplement. His new study, appearing online in the journal Respiratory Medicine, found a 59 percent improvement in lung function after an airway challenge, and a reduction in airway inflammation, asthma symptoms and use of emergency medication.
"Not only does it reduce symptoms, which will make you feel better, but it potentially could improve athletic performance," Mickleborough said. "Any time you can reduce medication is good."
In exercise-induced asthma, vigorous exercise triggers an acute narrowing of the airway afterward, making breathing difficult. Other symptoms include coughing, tightening of the chest and excessive fatigue. About 90 percent of people with asthma have this condition, which also is found in an estimated 10 percent or more of elite athletes and as much as 10 percent of the general population without asthma.
Mickleborough's study used Lyprinol/Omega XL, which contains PCSO-524, a patented extract of stabilized lipids from the New Zealand green-lipped mussel, combined with olive oil and vitamin E. PCSO-524 includes the five main lipid classes: sterol esters, sterols, polar lipids, triglycerides and free fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Previous studies involving PCSO-524 have found it to be effective in treating osteoarthritis, rheumatoid arthritis and inflammatory bowel disease. Mickleborough's study is the first to show that it is effective in reducing the airway inflammation experienced by asthmatic study participants diagnosed with exercise-induced asthma.
Mickleborough is chairing a symposium, "Health and Performance Benefits of Omega-3 Fatty Acids: Something Fishy Going On?" at 9 a.m. Saturday at the American College of Sports Medicine annual meeting in Indianapolis. Results from his PCSO-524 study will be discussed during a poster session at 8-9:30 a.m. on Thursday.
About the study:
The study involved 12 men and eight women ages 20 to 24 and was conducted in the Human Performance and Exercise Biochemistry Laboratory in the Department of Kinesiology at IU. All study participants had physician-diagnosed asthma and documented exercise-induced asthma. The study was conducted as a randomized, double-blind, placebo-controlled crossover trial. Study participants, none of whom took daily maintenance medication but all of whom used rescue inhalers, followed their regular diet for three weeks. Then, half took a placebo for three weeks while the rest took the supplement. They then followed their normal diet for two weeks. After that, they took the alternative supplement for three weeks. The placebo and PCSO-524 looked identical. A eucapnic voluntary hyperventilation challenge, which is a scientifically preferred substitute for an exercise challenge, was conducted at the beginning of the study and after each treatment period. Various measures of lung function and inflammation were collected before and after the eucapnic voluntary hyperventilation challenge, and study participants were asked to keep track of emergency inhaler use, symptoms and peak flow measurements.
Mickleborough plans to conduct further studies that look at the impact of PCSO-524 on delayed onset muscle soreness and delayed onset muscle damage. He also will examine whether the supplement can improve lung function and relieve airway inflammation in elite athletes who do not have asthma.
INFORMATION:
The research for "Marine lipid fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma," was supported by a grant from Pharmalink International LTD, which manufactures and owns PCSO-524. The funder had no role in study design, data collection and analysis, in writing the journal article, or the decision to publish.
Co-authors include Cherissa L. Vaughn, Ren-Jay Shei, Eliza M. Davis and Daniel P. Wilhite, all with the Department of Kinesiology in the IU School of Public Health-Bloomington.
For a copy of the study, contact the journal publisher at newsroom@elsevier.com.
Mickleborough can be reached at 812-855-0753 or tmickleb@indiana.edu. For additional assistance, contact Tracy James at 812-855-0084 or traljame@iu.edu.
About the School of Public Health-Bloomington
With nearly 3,000 students in an array of undergraduate and advanced degree programs, the School of Public Health-Bloomington offers a traditional campus experience enriched by 21st-century innovation. More than 120 faculty in five academic departments -- Department of Kinesiology; Department of Applied Health Science; Department of Recreation, Park and Tourism Studies; Department of Environmental Health; and Department of Epidemiology and Biostatistics -- conduct major research, teach and engage with communities across a broad spectrum of health, wellness and disease-prevention topics. Each department offers numerous majors, minors and opportunities for graduate and undergraduate studies. In addition to its academic departments, the school administers Campus Recreational Sports, which serves roughly 80 percent of the IU Bloomington student body through various intramural, club and individual sports opportunities.
IU study: Unique omega-3 source effective at reducing exercise-induced asthma symptoms
2013-05-28
ELSE PRESS RELEASES FROM THIS DATE:
UNC scientists identify possible KRAS downstream target for pancreatic cancer therapy
2013-05-28
CHAPEL HILL, N.C. - While the mutated KRAS oncogene is associated with many cancers, it has not yet been successfully targeted by a therapeutic agent. Scientists are trying to find another way to target the gene by blocking signals from another protein downstream.
A University of North Carolina School of Medicine team offers first evidence of the role of a protein called GSK-3 alpha in promoting oncogenic KRAS function. When the scientists inhibited GSK-3 in a model of pancreatic tumors, the team got a strong anti-tumor response, thus offering a potential therapeutic ...
Soda and illegal drugs cause similar damage to teeth
2013-05-28
CHICAGO (May 28, 2013)—Addicted to soda? You may be shocked to learn that drinking large quantities of your favorite carbonated soda could be as damaging to your teeth as methamphetamine and crack cocaine use. The consumption of illegal drugs and abusive intake of soda can cause similar damage to your mouth through the process of tooth erosion, according to a case study published in the March/April 2013 issue of General Dentistry, the peer-reviewed clinical journal of the Academy of General Dentistry (AGD).
Tooth erosion occurs when acid wears away tooth enamel, which ...
Children of long-lived parents less likely to get cancer
2013-05-28
The offspring of parents who live to a ripe old age are more likely to live longer themselves, and less prone to cancer and other common diseases associated with ageing, a study has revealed.
Experts at the University of Exeter Medical School, supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care in the South West Peninsula (NIHR PenCLAHRC), led an international collaboration which discovered that people who had a long-lived mother or father were 24% less likely to get cancer. The scientists compared ...
Researchers identify novel class of drugs for prostate cancers
2013-05-28
DALLAS – May 28, 2013 – A new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow.
In men with advanced prostate cancer, growth of cancer cells depends on androgen receptor signaling, which is driven by androgens, such as testosterone. To thwart tumor growth, most patients with advanced prostate cancer receive drugs that block the production of androgen or block the receptor where the androgen binds. Unfortunately, such treatments invariably ...
Striking green-eyed butterfly discovered in the United States
2013-05-28
A new butterfly species from Texas, given the common name Vicroy's Ministreak, was discovered because of its striking olive green eye color, and was given a formal scientific name (Ministrymon janevicroy). This beautiful new butterfly may be the last truly distinctive butterfly species to be discovered in the United States.
Although individuals of Vicroy's Ministreak were deposited in the Smithsonian entomology collections a century ago, this species was unrecognized because it was confused with the common, similar-looking Gray Ministreak. Interestingly what distinguishes ...
Fast-sinking jellyfish could boost the oceans' uptake of carbon dioxide
2013-05-28
The oceans absorb about 25 percent of the carbon dioxide (CO2) emitted by human activities. Since the industrial revolution, they have taken up about half of the man-made CO2. Billions of planktonic organisms, too tiny to be seen with the naked eye, make this valuable service possible: When carbon dioxide from the atmosphere dissolves in seawater, various species convert it to organic carbon and other organic components during photosynthesis. Jellyfish and pelagic tunicates live on smaller plankton and thus consume organic carbon. When they sink to the seafloor at the end ...
Men, women lie about sex to match gender expectations
2013-05-28
COLUMBUS, Ohio – People will lie about their sexual behavior to match cultural expectations about how men or women should act – even though they wouldn't distort other gender-related behaviors, new research suggests.
The study found that men were willing to admit that they sometimes engaged in behaviors seen by college students as more appropriate for women, such as writing poetry. The same was true for women, who didn't hide the fact that they told obscene jokes, or sometimes participated in other "male-type" deeds.
But when it came to sex, men wanted to be seen as ...
Digital chest tomosynthesis possible lung cancer screening tool
2013-05-28
DENVER – Most lung cancers are detected when patients become symptomatic and have late-stage disease. However, recently, computed tomography (CT) screening for lung cancer has been reported to reduce lung cancer mortality. Since the National Lung Screening Trial's results showed a 20 percent reduction in lung cancer-specific deaths in those patients who had screening performed with chest CT, the use of CT screening for lung cancer has been gaining favor. However, CT is associated with the disadvantages of high radiation dosage and cost.
Digital chest tomosynthesis (DT), ...
Research highlights the increasing problem of prescription drug abuse among youth
2013-05-28
Young people are increasingly turning to prescription drugs to get high. Research out of the University of Cincinnati sheds new light on what could increase or lower that risk.
The research by Keith King, a University of Cincinnati professor of health promotion; Rebecca Vidourek, a UC assistant professor of health promotion; and Ashley Merianos, a graduate assistant in health promotion, is published in the current issue of the Journal of Primary Prevention.
The study focused on more than 54,000 7th- through 12th - grade students in schools across Greater Cincinnati, ...
Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas
2013-05-28
DENVER – Sarcomatoid carcinomas of the lung include rare subtypes of poorly differentiated non–small-cell lung carcinomas of high grade and aggressive behavior. The biology of these neoplasms is poorly understood and these tumors are aggressive and resistant to chemotherapy and radiotherapy. The identification of actionable molecular targets for such infrequent and aggressive diseases is critical for design of new clinical trials.
Programmed death-1 (PD-1) is a co-inhibitory inducible receptor present on T-cells and macrophages. Tumor cells with increased programmed ...